Dan Loeb

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. Takeaways From 13F Season Investors who follow particular fund managers can easily look up what each was buying...

Activist investor and major Campbell Soup Company (NYSE: CPB) shareholder Dan Loeb is pushing the soup company to sell itself, but this is an unlikely outcome, according to JPMorgan. The Analyst JPMorgan's Ken Goldman downgraded Campbell Soup from Neutral to Underweight with an unchanged $...

The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. Takeaways From 13F Season Investors who follow particular fund managers can easily look up what each was...

Back in 2012, activist investors Carl Icahn and Dan Loeb pressured Yahoo to sell half its stake in Alibaba Group Holding Ltd (NYSE: BABA). While meant to unlock shareholder value, the campaigns ultimately stunted continued returns. Former CEO Marissa Mayer, who inherited Yahoo shortly after the...

The latest round of 13-F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. Takeaways From 13F Season Investors who follow particular fund managers can easily look up what each was...

Liliane Bettencourt, the world's richest woman and heiress to the conglomerate giant L'Oreal SA (ADR) (OTC: LRLCY), passed away Thursday at the age of 94. This raises the question of what will come next for the France-based L'Oreal; Bettencourt's family owns a 33 percent stake in L'Oreal while...

The latest round of 13-F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling. Here’s a rundown of how the smart money was playing some of the most popular stocks last quarter....

Dan Loeb’s Third Point released its quarterly letter to its investors on Wednesday. The fund earned 4.6 percent in the second quarter, bringing total returns for the year to 10.7 percent as of June 30. For comparison, the S&P 500 was up about 8.2 percent for the year as of June 30. During...

Activist investor Daniel Loeb's Third Point disclosed over the weekend a 3.28 billion Swiss franc ($3.4 billion) stake in the Switzerland-based giant Nestle SA (ADR) (OTC: NSRGY), best known for its chocolate products and beverages offerings. Third Point's stake in Nestle marks one of the biggest...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) investors were disappointed to see that popular vocal activist investor Bill Ackman finally abandoned his stake in Valeant for what was likely nearly a $4 billion loss on the trade. On the surface, a heavily-invested activist finally throwing in the...

Billionaire investor Dan Loeb said in a letter to clients on Wednesday that President Donald Trump's pro-business economic policies have "awakened animal spirits." As noted by CNBC, Loeb said in his letter that Trump's victory in the presidential election represents the "most important paradigm...

The battle between Bill Ackman and Herbalife Ltd. (NYSE: HLF), quite unbelievably, is still as heated as it ever was. For those unfamiliar with the story, Ackman is the hedge fund manager who famously (and publicly) bet $1 billion against the multi-level marketing company back in December 2012,...

Bill Ackman’s 2016 just keeps getting worse. With shares of Ackman’s most notorious long Valeant Pharmaceuticals Intl Inc (NYSE: VRX) already down 77.4 percent this year, Ackman short Herbalife Ltd. (NYSE: HLF) is spiking 18.1 percent on Friday following a $200 million settlement with...

Short interest in a number of stocks surged in the most recent settlement period. Two health care stocks were among those leading that trend in the first weeks of May. The number of shares short in one of them doubled for the second period in a row. It does not appear that short sellers have "...

The all but fantastical performance hedge funds have experienced recently may be coming to an end, according to a Reuters report warning that "there are several signs" the $2.9 trillion industry may be on the decline. Hedge funds, which were demanding hefty fees, are now facing "a storm of...